Clinical trial
GLucose Monitoring Programme SingaporE, Phase 2(GLiMPSE2)
NCT04564911 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GLucose Monitoring Programme SingaporE, Phase 2(GLiMPSE2)
- Lead sponsor
- Singapore General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 22, 2020
- Completion date
- December 30, 2023
- Enrollment
- 206 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 2, flash glucose monitoring